Bevacizumab, irinotecan, and temozolomide with re-irradiation in adult recurrent medulloblastoma: A first case report
2021
Abstract Medulloblastoma in adults is very rare, and there is no effective therapy for its initial appearance or recurrence. We present a case of a 40-year-old male with recurrent medulloblastoma despite initial radiochemotherapy. He received re-irradiation and 6 courses of bevacizumab, irinotecan, and temozolomide after which he remained stable for 6 months. This regimen may be promising for recurrent medulloblastoma in adults.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
-
Machine Reading By IdeaReader
23
References
0
Citations
NaN
KQI